XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Product Revenue, Net - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Revenue $ 11,369 $ 468
Gross product revenue | Customer | Cardinal Health    
Disaggregation of Revenue [Line Items]    
Concentration risk (percent)   22.20%
Gross product revenue | Customer | AmerisourceBergen Drug Corporation    
Disaggregation of Revenue [Line Items]    
Concentration risk (percent)   21.60%
Gross product revenue | Customer | McKesson Corporation    
Disaggregation of Revenue [Line Items]    
Concentration risk (percent)   20.80%
IBSRELA    
Disaggregation of Revenue [Line Items]    
Revenue $ 11,400 $ 500